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Bacterial meningitis is insufficiently diagnosed based on microscopic, cultural, and multiplex-
polymerase chain reaction (M-PCR). The use of already established universal method (UM) offers the 
ultimate solution to the detection and potential identification of bacteria in cerebrospinal fluid (CSF) 
samples. We have applied the UM together with a newly established Anchored Multiplex PCR (AMD4; 
Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and Listeria 
monocytogenes) to screen 130 CSF samples obtained from suspected meningitis cases for any 
bacterium. This two-stage UM approach was able to show that three of the samples contained bacterial 
DNA, only one of the three samples (K1) was shown to contain N. meningitidis whereas the other two 
samples (A35 and H1) were negative with AMD4. Nucleotide sequencing and BLAST analyses of 16S 
amplicons obtained by the UM from samples A35 and H1 showed no significant homology (<90%) to 
any available 16S sequence, yet indicated both bacteria (A35 and H1) to share 94.2% similarity. Both 
bacteria belonged to Gammaproteobacteria. The bacterium from sample K1 was isolated by culture and 
identified as N. meningitidis. The other two samples were negative by culture according to the clinical 
laboratories at both hospitals; A35 was from a patient who had received empirical antimicrobial therapy 
prior to sample collection. The remaining 127 samples were shown by the UM to be negative in 
accordance with clinical and laboratory findings. The UM can contribute significantly to the 
identification of bacterial meningitis cases to initiate empirical antimicrobial therapy within 3 h of 
sample collection. Simultaneously, bacterial meningitis can be ruled out from samples producing 
negative UM results. AMD4 application will detect and identify the major pathogens of  bacterial 
meningitis whereas the UM will detect any bacterium, UM can potentially identify any bacterium  as long 
as it is represented in the nucleotide databases; if not represented, it is labeled as unknown. We 
recommend the utilization of the UM in clinical testing; we also recommend culturing, characterization 
and identification of these unknown bacterial agents of meningitis as well as others. 
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INTRODUCTION 
 
Despite improvements in health care system, acute 
bacterial meningitis remains a life threatening infectious 
emergency (Chakrabarti et al., 2009). While most 
infections occur in infants, they are found in healthy 
children and adolescents as well. Successful treatment 
requires   rapid    detection    then    identification   of   the 
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bacterium (Saravolatz et al., 2003). Bacterial meningitis 
may lead to permanent neurological sequelae such as 
hearing loss, mental retardation, and seizures. Behavioral 
changes may occur in up to 50% of survivors, especially 
when diagnosis and treatment are delayed (Saravolatz et 
al., 2003; Dubos et al., 2008; Welinder-Olsson et al., 
2007). Potential long-term neurological sequelae include 
cranial nerve paralysis, hemiparesis, hydrocephalus, 
seizures as well as visual and hearing impairment which 
can have a profound impact on the  quality  of  life  of  the  
3416         Afr. J. Microbiol. Res. 
 
 
 
Table 1. Bacterial pathogens known to cause meningitis. 
 
Pathogen Source /References 
Acinetobacter baumannii Siegman-Igra et al.,1993; Kim et al., 2009 
Bacillus anthracis Ebrahimi et al., 2011 
Chryseobacterium meningosepticum Ozkalay et al., 2006  
Citrobacter farmer Tan et al., 2010 
Enterococcus spp. Poppert et al., 2005 
Escherichia coli  Brouwer et al., 2010; Porter, 2011 
Gemella haemolysans Anil et al., 2007 
Globicatella sanguinis Héry-Arnaud  et al., 2010 
Gram negative bacilli Kim et al., 2009; Porter, 2011 
Haemophilus influenzae  Failace et al., 2005; Porter, 2011 
Lactobacillus rhamnosus Robin et al., 2010 
Listeria monocytogenes  Brouwer et al. , 2010; Porter, 2011 
Mycobacterium tuberculosis  Thwaites et al., 2011 
Neisseria meningitidis Porter, 2011 
Proteus vulgaris Tebruegge et al., 2008 
Salmonella spp. Tebruegge et al., 2008 
Staphylococcus epidermidis Kim et al., 2009 
Staphylococcus spp., Staphylococcus aureus Brouwer et al., 2010 
  
Streptococcus spp., Streptococcus agalactiae  
Failace et al., 2005; Marchandin et al., 2005; Geiβdörfer et al., 2008;  
Domínguez-Punaro et al., 2010   
  
Streptococcus pneumoniae Marchandin et al., 2005; Porter, 2011 
Streptococcus spp. Group B Porter, 2011 
Streptococcus suis Domínguez-Punaro et al., 2010   
Ureaplasma urealyticum Geiβdörfer et al., 2008 
 
 
 
survivors. Death rate may reach 25% (Kim, 2003; 
Tebruegge and Curtis, 2008; Gray and Fedorko, 1992; 
Failace et al., 2005). Meningitis cases are usually 
attributed to a single agent; however, mixed infections 
are possible (Marchandin et al., 2005). Table 1 
summarizes the bacterial agents that have been reported 
to cause meningitis.  
Here, we propose a modified method for bacterial 
detection and identification. Previously, it has been 
demonstrated that 34 species distributed among 24 
bacterial genera could be detected and identified using 
primer pairs obtained from 16S rDNA sequence informa-
tion (Barghouthi, 2011), in addition, previous method 
(Failace, 2005) used for the detection of Neisseria 
meningitidis, Streptococcus pneumoniae, Haemophilus 
influenzae was modified to detect Listeria 
monocytogenes as well as other bacteria such as 
Staphylococcus epidermidis. Thus, AMD4, in combination 
with UM should be sufficient to rule out or detect 4 deadly 
meningitis causing bacteria and still simultaneously 
detect other bacterial DNA present in the sample. This 
two step Universal Method was applied for the detection 
of three bacteria from unrelated bacterial meningitis 
cases caused by different unknown 
Gammaproteobacteria that were reported as “no growth” 
by two clinical laboratories (from two samples) and one 
by N. meningitidis that was reported as “growth of N. 
menigitidis”. This work illustrates the validity of the two-
step UM in the direct detection and identification of 
bacteria from cerebrospinal fluid (CSF). Further efforts to 
isolate and characterize such bacteria are amply justified 
in the pursuit of understanding bacterial meningitis; 
antibiotic susceptibility, patient care, and epidemiology.                        
 
 
MATERIALS AND METHODS 
 
In the present study, a robust method for detection and 
identification of bacterial meningitis was applied. The method is a 
polymerase chain reaction (PCR) based system that amplifies 
segments of 16S rDNA bacterial gene allowing both detection and 
identification of CSF bacterial pathogens. Two methods are applied 
simultaneously to each CSF sample, the Universal Method golden 
primer mixture G7 which is a multiplex of 16S Alquds University 
General Primers: ( QUGP-Fn3: 5’-
CAGGATTAGATACCCTGGTAGTCC-3’; QUGP-F4: 5’-
CCGCCTGGGGAGTACG-3’;QUGP-Fn5: 5’-
ACTCCTACGGGAGGCAGCAG-3’; QUGP-Fn6: 5’-
CCAGCAGCCGCGGTAATAC-3’; QUGP-Rn1: 5’-
GGCTACCTTGTTACGACTTC-3’;QUGP-Rn2: 5’- 
TGACGGGCGGTGTGTACAAG-3’;QUGP-Rn3: 5’-
GGCGTGGACTACCAGGGTATC-3’) and  the anchored species 
specific PCR multiplex (AMD4; Table 2) were used for simultaneous  
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Table 2. The sequences of the species specific forward primers and their respective amplicon sizes are indicated. The sequences for QUGPs are given in the methods section.  
 
Specific forward primer 
Species specific PCR and sequencing primers 
(5’3’) 
Tm °C
 § Amplicon Size with anchor primer 
QUGP-Rn2 / QUGP-Rn3 
Haemophilus influenzae TGAGAGGCCGCATGCCATAGGATGA Φ 64°C 1201/ 600bp  
Klebsiella pneumoniae  Escherichia coli, Mycobacterium, and others¶ ATTGCACAATGGGCGCAAGCCTGAT 65°C 1044 /442bp 
Listeria monocytogenes Digestion of (TCCGGA)* AAGTGTGGCGCATGCCACGCTT Φ 65°C 1231 / 631 bp (381+250) 
Neisseria meningitidis TTTGTCAGGGAAGAAAAGGCTGTTGC Φ 61°C 969 /369 bp   
Staphylococcus epidermidis and others
Ω
 GCCTAATACATGCAAGTCGAGCGAACAG 62°C 1373/768 bp 
Streptococcus   pneumonia Digestion of (TCCGGA)* GTGTGAGAGTGGAAAGTTCACACTG Φ 58°C 952/351 bp (102+249bp) 
S. agalactia GCAAGTAGAACGCTGATGTTTGGTGTTTAC 61°C 1359/756 bp 
 
*Restriction enzymes that may cut the sequence TCCGGA are Bsp13I, Kpn2I, or BseAI producing the digestion products shown, Φ  AMD4 mix was made of indicated primers mixed with QUGP-Rn2 or 
QUGP-Rn3, sequences are given in the materials and methods section, § calculated Tm accounting for base-stacking, ¶ Include: Gulosibacter sp., Micrococcus luteus, K. oxytoca, K. variicola, 
Pseudoalteromonas sp., Pantoea agglomerans, P. eucalypti, P. ananatis, P. dispersa, Enterobacter cowanii, Serratia marcescens , among others, Ω Others include other Staphylococcus spp., Bacillus 
spp., Aerococcus spp. among others. 
 
 
 
detection and identification of bacteria in CSF samples. 
The protocol used for the detection and identification of 
bacterial pathogens in CSF samples is illustrated (Figure 
1). 
 
 
Patients  
 
Clinical CSF samples were collected from 130 suspected 
meningitis patients by lumber puncture, (neonates and 
internal word). All samples were tested by clinical 
laboratories using conventional methods (culture). For this 
study, a duplicate sample was obtained from Al Ahli 
Hospital (H samples), Alia Hospital (A samples), and 
Caritas Hospital (K samples) with appropriate permissions 
between January 2009 and August 2010. Duplicate CSF 
samples were collected in DNA free screw cap sterile 
microfuge tubes and stored at –65°C. 
 
 
DNA extraction from pure cultured reference species 
 
The most common CSF bacteria (N. meningitides, 
Haemophilus influenzae, Streptococcus pneumoniae, and 
Listeria monocytogenes) were obtained from Al-Quds 
University Bacterial Collection in the form of pure cultures 
(Barghouthi, 2011).  
To achieve a uniform DNA extraction procedure that is 
applicable to Gram positive and Gram negative bacteria, 
the following protocol was performed: Phosphate buffered 
saline PBS-2-mercaptoethanl mixture (PBS; NaCl 80 g, 
KCl 2.0 g, Na2HPO4 14.4 g, KH2PO4 2.4 g, pH 7.4, final 
volume 1 L H2O), 2-mercaptoehanol (2ME; Sigma 
Chemicals) was added to the autoclaved PBS; 0.5 µl/ml. 
As a reducing agent, 2ME may inhibit or inactivate 
bacterial enzymes such as proteases and nucleases that 
may interfere with the quality of DNA or the efficiency of 
the PCR reaction.  A 1 µl sterile plastic loop was used to 
transfer a loop-full of bacteria colonies to 400 µl of PBS-
2ME. After 5 min of incubation at ambient room tempera-
ture, the bacterial cells were collected by centrifugation at 
13,000 rpm for 1 min (Hettich microcentrifuge, Tuttlingen, 
Germany), supernatant was aseptically discarded. To the 
remaining pellet 50 µl of lysis mixture (25 µl of 0.5N NaOH 
and 25 µl of 1% Sodium Dodecyl Sulfate; SDS) were 
added, mixed, and steamed over a boiling water bath for 
10 min. The lysate was diluted with 150 µl of sterile pure 
water, mixed, and centrifuged for 3 min at 13,000 rpm, the 
supernatant was then used in PCR reactions. The 
remaining supernatant was transferred to a fresh sterile 
screw cap microfuge tube and stored at -65°C for further 
use. 
 
 
Bacterial DNA extraction from CSF samples  
 
One hundred microlitre of CSF sample  were placed in a 
labeled sterile screw cap microfuge tube, 0.5 µl of 2-
mercaptoethanol (2ME) was added, after incubation at 
37°C for 5 min, centrifuged for 2 min at 13,000 rpm, 
supernatant was removed and appropriately discarded. 
The remaining steps for DNA extraction were exactly as 
described above. 
 
 
Universal method bacterial detection and anchored-
multiplex PCR   
 
The UM was applied as described by Barghouthi (2011). 
Briefly, the golden mixture multiplex (G7) which amplifies 
any of the ten target sequences distributed among 
bacterial 16S rDNA genes. G7 takes advantage of the 
probability of any one of those 10 sequence of appearing in 
any bacterium, G5 supplies another 3 target sequences 
that can be applied as well. UM detects all bacteria and 
identifies many bacterial species (Barghouthi, 2011). One 
of the produced PCR products is then sequenced for 
bacterial identification through BLAST analysis of available 
DNA sequences in gene data bases (Altschul et al., 1990; 
BLAST, 2001).  
The anchored-multiplex (AM) method is a modified 
multiplex that was developed for this study. The two 
general reverse primers (QUGP-Rn2 or QUGP-Rn3; Table 
2) that represents most bacteria; particularly those causing 
meningitis: N. meningitidis, S. pneumoniae, H. influenzae, 
L. monocytogenes, S. aureus, enterobacteria and others 
were QUGP-Rn2   and    QUGP-Rn3   (Barghouthi,   2011).  
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Figure 1. Bacterial detection and identification working plan.   
 
 
 
QUGP-Rn2 produces longer PCR amplicon with the forward 
species specific primers than does QUGP-Rn3. Table 2 shows the 
expected PCR amplicons with different bacteria when QUGP-Rn2 
or QUGP-Rn3 are used. All primers were designed to be functional 
at a fixed annealing temperature of > 58°C as determined by the 
online Tm calculator (www.promega.com). The primers used in this 
study to generate Anchored-Multiplex D4 (AMD4) and others are 
shown in Table 2. 
AMD4 is a mixture containing the four species specific forward 
primers and the QUGP-Rn3 or QUGP-Rn2, the multiplex was 
named AMD4, since the QUGP-Rn3 or Rn2 served as the 
reference point to determine the PCR product size. Species specific 
primers were also tested individually with one of the general 
QUGPs primers. The mixture was directed against N. meningitidis, 
S. pneumoniae, H. influenzae, and L. monocytogenes. The concept 
of the anchored –multiplex takes advantage of the fact that the two 
reactions (G7 and AM) can be applied simultaneously or 
sequentially to reduce the requirement for amplicon sequencing 
and to facilitate bacterial identification. The following procedure was 
performed: One hundred pmol (10 µl) of each specific forward 
primer was mixed with 40 µl (400 pmol) of one of the reverse 
primers (QUGP-Rn2 or Rn3) and 20 µl of sterile, DNA-free water. 
This produced 10 pmol/ µl concentration of each primer, except for 
the reverse primer which was used at 40 pmol to prevent its 
depletion in case of the presence of more than one target sequence 
and to balance the forward primers. PCR reactions were carried out 
as 25 µl-reactions in thin walled tubes; primers and DNA were 
added at 0.5 µl each (Ready MasterMix, Promega Biochemical 
company). Short amplicons obtained with QUGP-Rn3 produced 
better band resolution than the  long  amplicons  seen  with  QUGP- 
Rn2 (Table 2). 
 
 
RESULTS AND DISCUSSION 
 
AMD4 was prepared by mixing the general reverse 
primer QUGP-Rn2 or -Rn3 with the species specific 
primers. When AMD4 was applied specifically to each 
one of the reference bacterial species, specific PCR 
amplicons were generated (Figure 2). AMD4 (QUGP-
Rn2) produced the appropriate PCR amplicons; a 952 bp 
amplicon with S. pneumoniae; a 1201 bp amplicon with 
H. influenzae; a 969 bp amplicon with N. meningitidis; 
and 1231 bp amplicon with L. monocytogenes. Other 
potential bacterial pathogens (Klebsiella pneumoniae, 
Escherichia coli, and Staphylococcus epidermidis) were 
tested individually; using their specific forward primers 
anchored to one of the reverse primers QUGP-Rn2 or 
QUGP-Rn3 they produced the predicted PCR amplicons 
(Table 2).  The results (Figure 2A) illustrate that AMD4 
produced amplicons identical to those obtained when 
each specific primer was applied separately (Figure 2B). 
The results also showed the lack of cross reactivity 
between primers and other non-target inter-or intra-
species DNA, emphasizing the specificity of the AMD4 
mixture. Amplicons obtained with AMD4 were in complete 
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Fiugure 2. (A) Amplicons produced with Anchored Multiplex D4 
(AMD4) using the reverse primer QUGP-Rn2 for each of four bacterial 
pathogens. Lanes: 1, 100-bp molecular markers; 2, 1Kbp Markers; 3, 
Streptococcus pneumoniae 952bp amplicon; 4, Haemophilus 
influenzae 1201 bp; 5, Neisseria meningitidis 969bp; 6, Listeria 
monocytogenes 1231bp. (B) Amplicons produced without multiplex 
from direct application of each specific forward primer with QUGP-Rn2, 
lanes are as in panel A, non-specific bands ~300bp (NS) were only 
observed in panel B and absent from panel A . Lanes with the same 
number contain the same bacterial amplicon (lanes 3 and 5 are 
switched in panel B).  
 
 
 
agreement with the theoretically predicted PCR 
amplicons (Figure 2 and Table 2).  
 
 
Sensitivity of the AMD4 multiplex 
 
The ability of AMD4 to detect target bacteria in CSF 
samples was tested and established. Reference bacterial 
colony was serially diluted in human CSF that was judged 
to be bacteria-free by its negative reaction to UM-G7. 
AMD4-PCR was then applied to DNA extracted from 
each dilution. The results showed that AMD4 was able to 
specifically detect bacteria diluted in CSF (Figure 3A). 
AMD4 was able to generate shorter amplicons when 
QUGP-Rn2 was replaced by QUGP-Rn3 (Figure 3B).    
 
 
Clinical CSF samples 
 
Molecular detection of bacteria in CSF from 130 clinical 
samples collected from three different hospitals in 
Southern West Bank, Palestine, has successfully shown 
127 samples to have no bacterial DNA indicating the 
absence of bacterial meningitis. Typical PCR negative 
samples tested with UM-G7 are shown (Figure 4). 
The remaining three samples (A35, H1, and  K1)   were  
positive by UM-G7. When these three samples were 
tested with AMD4, only sample K1 produced a unique 
PCR product (969 bp) indicative of N. meningitidis. The 
result was in accordance with the hospital clinical 
laboratory culture results where N. meningitidis was 
isolated.  
The two unknown amplicons obtained with G7 (QUGP-
Fn6 and QUGP-Rn3) from clinical sample A35 and H1 
(Figure 4) were subjected to nucleotide sequencing 
followed by BLAST analysis. The results (Figure 5A and 
B) indicated that A35 and H1belonged to 
Gammaproteobacteria. To show that the two bacteria 
were different, amplicon sequence of H1 was aligned 
against that of A35. Similarity was found to be 94.2% 
indicating non-identity (Figure 6). The results were 
consistent with patient clinical findings but disagreed with 
clinical laboratory findings which reported the two cases 
as “no growth”.   
Aseptic CSF sample processing is critical; collection of 
CSF sample in DNA-free tubes, DNA extraction from 100 
µl-samples (larger CSF volumes can be used), treatment 
of samples with 2-mercaptoethanol, and washing steps 
which ensured successful PCR-based detection and 
identification, were established. One of the aims was to 
identify CSF samples that were free of bacteria, 
especially since the UM-G7 detection is  sensitive  to  any  
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Figure 3A. Sensitivity of bacterial detection 
with AMD4 (QUGP-Rn2). Bacterial colony was 
serially diluted in bacteria-free CSF. Each 
PCR reaction received DNA equivalent to 2.5 
CFU. Neisseria meningitidis 969bp, lane2; 
Haemophilus influenzae 1201bp, lane 3; 
Streptococcus pneumoniae 952bp, lane 4. 
Dilutions were made in 100 µl aliquots of 
bacteria-free human CSF.  DNA was then 
extracted from each dilution into 200 µl. 
Amplification was carried out on 0.5 µl of 
extracted DNA.   
 
 
 
bacterial DNA contamination and may result in increased 
false positive results. The 127 UM-negative samples 
were consistent with clinical laboratory findings; CSF 
samples that were collected in containers and the empty 
containers themselves (other than the screw cap sterile 
microfuge tubes) had produced positive results with UM-
PCR indicating that contaminated containers sterilized by 
radiation or gas application most likely will produce 
positive UM-G7 amplification, probably due to the 
presence of preserved bacterial DNA. This problem was 
solved by direct collection of CSF samples into sterile 
screw-cap microfuge tubes. 
The AMD4 was designed to quickly identify the major 
bacterial species associated with meningitis.  The 
concept of Anchored Multiplex addressed two important 
issues; firstly, one reverse primer shared by all target 
bacteria will act as a reference point (anchor) to all 
amplicons whereas the species specific forward primer 
will dictate the size of amplicon and makes it 
distinguishable from other bacterial species. Secondly, 
the utility of anchoring primer (QUGP Rn2 or Rn3) 
substituted for the use of the species specific reverse 
primers and reduced  the  number  of  primers  within  the  
 
 
 
 
 
 
Figure 3B. AMD4 (QUGP-Rn3) generated smaller PCR 
products that improved resolution of PCR bands; lane l  N. 
meningitidis 370bp; lane 2 H. influenzae  600bp; lane 3 S. 
pneumoniae 351bp; and lane 4 L.monocytogenes  631 bp. To 
discriminate S. pneumoniae, its amplicon can be digested with 
Bsp13I that does not digest N. meningitidis amplicon (Table 2).  
 
 
 
multiplex AMD4 (AMD4 contained five primers; four 
forward and one reverse instead of 8 primers). Such 
strategy, allows for the incorporation of additional 16S 
species specific forward primers. Although a non-specific 
band (~300 bp) was observed (Figure 2B), the band was 
absent or less evident when AMD4 was utilized for 
amplification, (Figure 2A). 
Another criterion that was standardized in this study 
was the amplification reaction annealing temperature; all 
primers were designed to function at Ca ~60°C. 
Accordingly, both AMD4 and UM were carried out using 
the same PCR-amplification parameters. The choice of 
60°C as the annealing temperature had several advan-
tages over other annealing temperatures; prevention of 
inter-and intra-primer pairing and hairpin formation 
especially with GC rich primer regions and the provision 
of an extended free 3´-end. Bacterial specific primers 
needed to be 16-28 nucleotide long based on their 
sequences and GC content, 60°C was suitable for all 
primers. This feature allowed simultaneous testing of 
CSF samples using AMD4 and UM under the same 
amplification conditions. If a CSF sample was negative 
with both methods, it was scored as free of bacterial 
DNA, if a sample was positive, as in sample K1, with both 
methods, it was simultaneously identified as N. 
meningitidis based on amplicon size. However, when 
only UM-G7 was positive as with samples H1 and A35 
(negative reactions with AMD4.), the Universal Method 
identification was utilized in bacterial identification. H1 
and A35 were missed by cultural and microscopic 
methods conducted by hospital clinical laboratory. 
Clinically,   bacterial   meningitis was  indicated  by  fever,  
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Figure 4. Positive and negative CSF samples with UM-G7, only positive samples are indicated the remaining 9 
samples (1-9) were negative.  The 290bp amplicons produced  by the action of QUGP Fn6 and QUGP Rn3 were 
detected  in samples K1, H1, and A35 when subjected to UM-G7. K1, H1, and A35 were from three different hospitals. 
 
 
 
 
 
Figure 5A. 273-nucleotide DNA sequence obtained for sample A35 with QUGP-Rn3 primer. Notice that the underlined 
3’-end sequence is complementary to the sequence of QUGP- Fn6 used in the amplification process. The 3’-end 
adenine (bold) may have been added by Taq DNA polymerase in a template-independent fashion (Geiβdörfer et al., 
2008).   
 
 
 
 
 
Figure 5B. 271-nucleotides DNA sequence obtained for sample H1 with QUGP-Rn3, the underlined sequence is 
complementary to QUGP-Fn6.  
 
 
 
CSF physical properties, leukocyte counts, and CSF-
glucose level. Sample A35 was from a 4-year old patient 
who presented with fever, the culture results and gram 
stain were negative, possibly due to antimicrobial 
treatment that had been commenced prior to lumbar 
puncture/CSF sample collection; bacterial  meningitis 
was evident from high white blood cell counts (WBC) and 
low CSF-glucose level. The UM-G7 successfully detected 
the bacterial presence in this sample (A35) even though 
antibiotic was administered prior to sample collection. 
The 290 bp UM-G7 amplicon (generated by QUGP-
Fn6●QUGP-Rn3) was sequenced in both directions. 
BLAST alignment failed to detect identical bacterium, but 
indicated that the bacterium was most closely related to 
Gammaproteobacteria (92%; Figure 4; 
http://www.bacterio.cict.fr/g/gammaproteobacteria.html ). 
Gamma (2011). 
The second UM-positive  sample  (H1);  was  from  a  3  
5’-TTCCTGTTTGCCTACCGCTTTCGCGCCTGCAGCGTCAGTAATGGGAAGGCAGGGAGCCGC 
TTGCCACTGGTGTTCCTCCCGATATTTACGCATTTCACCGCTACACCGGGAATTCCACTCCCCTCTGCCGTA
CTCTAGCCAGCCAGTTTCAAATGCAGTTCCCAGGTTGAGCCCGGGGATTTCACATCTGACTTAACTAACCGC
CTACGCGCGCTTTACGCCCAGTAATTCCGATTAACGCTTGCACCCTTCGTATTACCGCGGCTGCTGGA-3’  
                                                                                  A 
5’-ACCTGTTTGCTTACAGCTTTCGCGCCTGAGCGTCAGTAACTGGGACCAGGGAGCC 
GCCTCCGCCACTGGTGTTCCTCCCGATATCTACGCATTTCACCGCTACACCGGGAATTCCACTCCCCTCTGC
CGTACTCTAGCCAGCCAGTATCAAATGCAGTTCCCAGGTTGAGCCCGGGGATTTCACATCTGACTTAACTAA
CCGCCTACGCGCGCTTTACGCCCAGTAATTCCGATTAACGCTTGCACCCTTCGTATTACCGCGGCTGCTGG-
3’ 
                                                                 B 
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Figure 6. Emboss conducted alignment of A35 amplicon against H1 amplicon showed 94.2% similarity which 
indicated two different Gammaprotobacteria (BLAST results are not shown). 
 
 
 
growth”. UM was able to detect bacterial presence, 
sequencing and BLAST analysis indicated that bacterium 
was related to Gammaproteobacteria but different from 
A35 isolate (Figure 6). 
Two important issues remain to be critically addressed; 
the possible contamination of the CSF sample with 
exogenous bacteria and the antibiotic susceptibility of the 
identified bacterial pathogen. As emphasized above, 
aseptic CSF collection in DNA-free containers, 
processing the minimum amount of CSF sample, and 
sequencing of amplicons may be sufficient to rule out 
contamination for the following reasons. Assuming low 
level contamination (<1000 cells/ml CSF) will escape 
PCR sensitivity levels producing negative results if less 
than 0.25 bacterial chromosome is introduced into the 
PCR reaction (since most bacteria harbor 4 copies of the 
16S gene per chromosome, some species show more 
than one chromosome; usually 2), this can be achieved 
when processing 100 µl of CSF are extracted into >200 µl 
and only 0.5 µl of the extract is applied to the PCR 
reaction, most probably will result in a negative PCR 
reaction. Simultaneously, another assumption has to be 
made; clinical bacterial meningitis cases must show 
bacterial counts of >1000 cells/ml of CSF to be 
detectable by the same calculations. Higher levels of 
contamination (> 1000 cells/ml of CSF) will produce 
positive UM-G7 amplicons, such contaminations may be 
caused by a single species or a mixture of bacteria and 
will produce a false positive result when the case is a true 
negative case of bacterial meningitis. On the other hand, 
contamination will confuse true positive meningitis cases. 
In other words, a CSF sample that is UM-G7 positive 
should be treated as a true positive sample since 
bacterial meningitis cannot be ruled out. The case of 
bacterial meningitis can be further complicated by mixed 
infections and sample contamination which complicate 
diagnosis. In cases of spine or brain (CNS) 
neurosurgeries prophylactic and post-surgical antibiotic 
therapy are administered regardless of infection 
(Marchandin et al., 2005).    
Samples H1 and A35 are unlikely to be the result of 
contamination since 97.7% of all the samples (127/130) 
were UM-G7-negative indicating excellent aseptic 
techniques. In addition, high-level contamination (>1000 
cells/ml of CSF) is required to be detectable by PCR; 
high   level   contamination   most    likely   is   a   “mixed”  
 
 
 
 
contamination and will prevent useful sequencing and 
alignment (BLAST, 2011). 
Samples H1 and A35 most probably contained a single 
type of bacterium that only produced a pure amplicon 
which in turn produced clean sequences. The identified 
bacteria were related to the Gram negative 
Gammaproteobacteria which is consistent with Gram 
negative rods/bacilli reported to cause meningitis (Table 
1).      
The second problem is the determination of antibiotic 
susceptibility of bacterial pathogens; this problem is 
inherent to all molecular techniques; unlike culture, disc 
diffusion, and E-test. Molecular techniques do not allow 
complete antibiotic profiling of the pathogen, although 
attempts have been successful in showing certain 
markers of antibiotic resistance, yet they fall short of 
providing a practical and reliable antibiotic susceptibility 
profiling for therapeutic decision making.     
In conclusion, the UM potential to rule out bacterial 
meningitis was illustrated; all UM negative samples (127 
CSF samples) were in agreement with clinical and 
laboratory findings in ruling out bacterial meningitis. The 
UM-G7 showed unprecedented potential for its capacity 
to detect and identify bacterial pathogens. The UM only 
limitation for identifying bacterial pathogens was its 
reliance on the availability of DNA sequences for BLAST 
analysis, but data bases are growing as new sequences 
are added. A cultured spiral bacterium (QUBC 70) was 
not identified after sequencing and BLAST due to the 
absence of identical sequences from available nucleotide 
bases (Barghouthi, 2011). Later, BLAST showed QUBC 
70 to share 99% of its amplicon sequence with 
Alphaproteobacteria. The number of available complete 
genome sequences was 1860 in March, 2011 and 2001 
genomes in February 2012. Additional sequences are 
available through Nucleotide bases, yet none of the data 
bases are complete (BLAST; nucleotide BLAST, 2011). 
New pathogens may be identified such as those detected 
in samples H1 and A35, they were Gram negative, 
Gammaprotobacteria which encompasses several known 
pathogenic bacteria (Gamma). We hope that UM and 
UM-G7 be adopted by most clinical laboratories for the 
diagnosis of bacterial meningitis and bacteremia.  
This work emphasizes the need to re-focus attention at 
bacterial agents that may be involved in bacterial 
meningitis. It calls for the full investigation, culturing, 
identification, and characterization of bacterial pathogens 
involved in meningitis. The under reporting of bacterial 
meningitis may be simply due to inadequate detection 
and culturing methods applied by clinical laboratories. 
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